Public engagement and clinical trials : new models and disruptive technologies : workshop summary /

Saved in:
Bibliographic Details
Meeting name:Public Engagement and Clinical Trials: New Models and Disruptive Technologies (2011 : Mount Sinai School of Medicine)
Imprint:Washington, D.C. : National Academies Press, 2011.
Description:1 online resource (xvi, 124 pages) : color illustrations
Language:English
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11121665
Hidden Bibliographic Details
Other authors / contributors:Weisfeld, Victoria D.
English, Rebecca A.
Claiborne, Anne B.
Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
ISBN:9780309219297
0309219299
9780309219303
0309219302
0309219299
Notes:Includes bibliographical references (pages 85-87).
Summary:"Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description.
Other form:Print version: Public Engagement and Clinical Trials. Washington, D.C. : National Academies Press, ©2011 9780309219297

MARC

LEADER 00000cam a2200000Ia 4500
001 11121665
005 20210426223521.4
006 m o d
007 cr cn|||||||||
008 111205s2011 dcua ob 100 0 eng d
016 7 |a 101582836  |2 DNLM 
016 7 |a 016066521  |2 Uk 
019 |a 760055026  |a 772459094  |a 971092635  |a 988460703  |a 991919289  |a 1037929686  |a 1038664408  |a 1045551101  |a 1047527785  |a 1058168116  |a 1153534888 
020 |a 9780309219297  |q (e-book) 
020 |a 0309219299  |q (e-book) 
020 |a 9780309219303  |q (electronic bk.) 
020 |a 0309219302  |q (electronic bk.) 
020 |z 0309219299 
035 |a (OCoLC)769188485  |z (OCoLC)760055026  |z (OCoLC)772459094  |z (OCoLC)971092635  |z (OCoLC)988460703  |z (OCoLC)991919289  |z (OCoLC)1037929686  |z (OCoLC)1038664408  |z (OCoLC)1045551101  |z (OCoLC)1047527785  |z (OCoLC)1058168116  |z (OCoLC)1153534888 
035 9 |a (OCLCCM-CC)769188485 
040 |a E7B  |b eng  |e pn  |c E7B  |d IDEBK  |d N$T  |d MMU  |d YDXCP  |d TPH  |d OCLCQ  |d CDX  |d UCNAP  |d ZMC  |d OCLCQ  |d OCLCA  |d OCLCF  |d NLGGC  |d COO  |d OCLCQ  |d VT2  |d OCLCQ  |d AGLDB  |d TOA  |d MOR  |d OCLCO  |d PIFAG  |d OCLCQ  |d OCLCA  |d BUF  |d OCLCO  |d STF  |d VNS  |d WRM  |d VTS  |d NRAMU  |d EZ9  |d ICG  |d MERER  |d REC  |d AU@  |d OCLCQ  |d OCLCO  |d LVT  |d M8D  |d OCLCQ  |d OCLCO  |d OCLCA  |d UKCRE  |d AJS 
043 |a n-us--- 
049 |a MAIN 
050 4 |a R853.C55  |b P83 2011eb 
060 4 |a QV 771 
072 7 |a MED  |x 047000  |2 bisacsh 
111 2 |a Public Engagement and Clinical Trials: New Models and Disruptive Technologies  |d (2011 :  |c Mount Sinai School of Medicine)  |0 http://id.loc.gov/authorities/names/no2012029643 
245 1 0 |a Public engagement and clinical trials :  |b new models and disruptive technologies : workshop summary /  |c Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. 
260 |a Washington, D.C. :  |b National Academies Press,  |c 2011. 
300 |a 1 online resource (xvi, 124 pages) :  |b color illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references (pages 85-87). 
520 |a "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description. 
505 0 0 |t Introduction --  |t Framing the problem --  |t Recruitment challenges in clinical trials for different diseases and conditions --  |t Models for public health engagement --  |t The media --  |t Novel clinical trial designs --  |t The health system's structure and culture --  |t Toward a patient-centered strategy for clinical trials. 
650 0 |a Clinical trials.  |0 http://id.loc.gov/authorities/subjects/sh85027069 
650 1 2 |a Clinical Trials as Topic. 
650 1 2 |a Patient Participation. 
650 2 2 |a Drug Evaluation. 
650 2 2 |a Patient Education as Topic. 
651 2 |a United States. 
650 7 |a MEDICAL  |x Laboratory Medicine.  |2 bisacsh 
650 7 |a Clinical trials.  |2 fast  |0 (OCoLC)fst00864429 
655 0 |a Electronic books. 
655 4 |a Electronic resource. 
655 4 |a Electronic books. 
700 1 |a Weisfeld, Victoria D.  |0 http://id.loc.gov/authorities/names/n89630070 
700 1 |a English, Rebecca A.  |0 http://id.loc.gov/authorities/names/no2010177259 
700 1 |a Claiborne, Anne B.  |0 http://id.loc.gov/authorities/names/no2011029945 
710 2 |a Institute of Medicine (U.S.).  |b Forum on Drug Discovery, Development, and Translation.  |0 http://id.loc.gov/authorities/names/no2007051854 
776 0 8 |i Print version:  |t Public Engagement and Clinical Trials.  |d Washington, D.C. : National Academies Press, ©2011  |z 9780309219297  |w (OCoLC)767570602 
856 4 0 |u http://dx.doi.org/10.17226/13237  |y National Academies Press 
856 4 0 |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=400080  |y eBooks on EBSCOhost 
903 |a HeVa 
929 |a oclccm 
999 f f |i 0c91018b-535a-5a04-b70a-75caab81c366  |s 354c65ef-4e19-56b2-aaa7-1bee21bda35b 
928 |t Library of Congress classification  |a R853.C55 P83 2011eb  |l Online  |c UC-FullText  |u http://dx.doi.org/10.17226/13237  |z National Academies Press  |g ebooks  |i 12360691 
928 |t Library of Congress classification  |a R853.C55 P83 2011eb  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=400080  |z eBooks on EBSCOhost  |g ebooks  |i 12360692